Seroprevalence of HTLV-1 among kidney graft recipients: A single-center study

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Khameneh, Zakieh Rostamzadeh ^a   Sepehrvand, Nariman ^a   Masudi, Sima ^a   Taghizade Afshari, Ali ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Elisa; Human t lymphocyte virus type 1; Renal transplant

Indexed keywords

CYCLOSPORIN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IRAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; WESTERN BLOTTING;

EID: 77954096880     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. González-Pérez MP, Muñoz-Juárez L, Cárdenas FC, Zarranz Imirizaldu JJ, Carranceja JC, García-Saiz A. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation. 2003;75(7):1006-1011.
2. Siegel RS, Gartenhaus RB, Kuzel TM. Human T-cell lymphotropic-I-associated leukemia/lymphoma. Curr Treat Options Oncol. 2001;2(4):291-300.
3. Farid R, Poryamoth N, Godarzi A. A familial seroepidemiological survey of HTLV-1 in Mashhad, Northeastern Iran suggested an important mother to child transmision. J AIDS Hum Retrovirol. 1995;10:209-212.
4. Rezvan H, Ahmadi J, Farhadi MA. Cluster of HTLV-1 infection in North-Eastern of Iran. Transfusion Today. 1996;27:1-9.
5. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008;19(5):838-841.
6. Karimi A, Nafisi M. Seroprevalence of Human T-Cell Leukemia Virus Type-1 (HTLV-1) in High Risk Patients. J Res Health Sci. 2006;6(1):44-47.
7. PourKarim MR, KhamisiPour GR, Hajiani GR. Seroepidemiologic survey of HTLV-I/II among frequent blood recipients of Bushehr province-Iran. Khoon (hematology) Res J. 2005;4:99-103.
8. Nakatsuji Y, Sugai F, Watanabe S, et al. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci. 2000;177(2):154-156.
9. Villafruela Mateos A, Arruza Echevarría A, Martín Bazaco J, Azurmendi Arin I, Zabala Eugurrola JA, Pertusa Peña C. HTLV infection after renal transplant [in Spanish]. Arch Esp Urol. 2005;58(10):1064-1068.
10. Zarranz Imirizaldu JJ, Gomez Esteban JC, Rouco Axpe I, et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry. 2003;74(8):1080-1084.
11. Nakamura N, Arakaki Y, Sunagawa H, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc. 1998;30(4):1324-1326.
12. Nakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc. 2005;37(4):1779-1782.
13. Linhares MI, Eizuru Y, de Andrade GP, et al. Human T cell leukemia virus type 1 (HTLV-1) antibodies in healthy populations and renal transplanted patients in the north-east of Brazil. Microbiol Immunol. 1994;38(6):475-478.
14. Perez G, Ortiz-Interian C, Bourgoignie JJ, et al. HIV-1 and HTLV-I infection in renal transplant recipients. J Acquir Immune Defic Syndr. 1990;3(1):35-40.
15. Morikawa K, Kuroda M, Tofuku Y, et al. Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan. Am J Kidney Dis. 1988;12(3):185-193.
16. Remesar MC, del Pozo AE, Pittis MG, Mangano AM, Sen L, Briones L. Transmission of HTLV-I by kidney transplant. Transfusion. 2000;40(11):1421-1422.
17. Kauffman HM, Taranto SE. Human T-cell lymphotrophic virus type-1 and organ donors. Transplantation. 2003;76(4):745-746.